Hauptmenü öffnen

CK-Wissen β

Literatur

  • Chabi A, Zhang Y, Jackson S, Cady R, Lines C, Herring WJ, Connor KM, Michelson D (August 2014). "Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis". Cephalalgia. doi:10.1177/0333102414544979. PMID 25106663. 
  • Katagiri A, Okamoto K, Thompson R, Rahman M, Bereiter DA (June 2014). "Posterior hypothalamic modulation of ocular-responsive trigeminal subnucleus caudalis neurons is mediated by Orexin-A and Orexin1 receptors". Eur. J. Neurosci.. doi:10.1111/ejn.12635. PMID 24904977. 
  • Thompson, MD.; Xhaard, H.; Sakurai, T.; Rainero, I.; Kukkonen, JP. (May 2014). "OX1 and OX2 orexin/hypocretin receptor pharmacogenetics.". Front Neurosci 8: 57. doi:10.3389/fnins.2014.00057. PMID 24834023.  - Free full text.
  • Jan Hoffmann, Weera Supronsinchai, Christopher Winrow, John Renger, Richard Hargreaves and Peter Goadsby (Febr 2013): Dual Orexin Receptor Antagonists Inhibit Nociceptive Neuronal Activity in the Trigeminocervical Complex of the Rat. (S55.006) Neurology. 80 (Meeting Abstracts 1) URL
  • Ho, YC.; Lee, HJ.; Tung, LW.; Liao, YY.; Fu, SY.; Teng, SF.; Liao, HT.; Mackie, K.; et al. (Oct 2011). "Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.". J Neurosci 31 (41): 14600-10. doi:10.1523/JNEUROSCI.2671-11.2011. PMID 21994376. 
  • Cevoli, S.; Pizza, F.; Grimaldi, D.; Nicodemo, M.; Favoni, V.; Pierangeli, G.; Valko, PO.; Baumann, CR.; et al. (Jun 2011). "Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.". Cephalalgia 31 (8): 973-6. doi:10.1177/0333102411403634. PMID 21444644. 
  • Chiou, LC.; Lee, HJ.; Ho, YC.; Chen, SP.; Liao, YY.; Ma, CH.; Fan, PC.; Fuh, JL.; et al. (2010). "Orexins/hypocretins: pain regulation and cellular actions.". Curr Pharm Des 16 (28): 3089-100. doi:10.2174/138161210793292483. PMID 20687883. 
  • Gatfield, J.; Brisbare-Roch, C.; Jenck, F.; Boss, C. (Aug 2010). "Orexin receptor antagonists: a new concept in CNS disorders?". ChemMedChem 5 (8): 1197-214. doi:10.1002/cmdc.201000132. PMID 20544785. 
  • Hassani OK, Henny P, Lee MG, Jones BE (August 2010). "GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep". Eur J Neurosci 23 (3): 448-57. doi:10.1111/j.1460-9568.2010.07295.x. PMID 20597977. 
  • Rainero, I.; De Martino, P.; Pinessi, L. (Mar 2008). "Hypocretins and primary headaches: neurobiology and clinical implications.". Expert Rev Neurother 8 (3): 409-16. doi:10.1586/14737175.8.3.409. PMID 18345971. 
  • Cevoli, S.; Mochi, M.; Pierangeli, G.; Zanigni, S.; Grimaldi, D.; Bonavina, G.; Torelli, P.; Manzoni, GC.; et al. (Feb 2008). "Investigation of the T3111C CLOCK gene polymorphism in cluster headache.". J Neurol 255 (2): 299-300. doi:10.1007/s00415-008-0719-8. PMID 18283403. 
  • Schürks, M.; Limmroth, V.; Geissler, I.; Tessmann, G.; Savidou, I.; Engelbergs, J.; Kurth, T.; Diener, HC.; et al. (Sep 2007). "Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene.". Headache 47 (8): 1195-9. doi:10.1111/j.1526-4610.2007.00863.x. PMID 17883525. 
  • Rainero, I.; Rubino, E.; Valfrè, W.; Gallone, S.; De Martino, P.; Zampella, E.; Pinessi, L. (Jun 2007). "Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis.". J Headache Pain 8 (3): 152-6. doi:10.1007/s10194-007-0383-x. PMID 17563843. 
  • Schürks, M.; Kurth, T.; Geissler, I.; Tessmann, G.; Diener, HC.; Rosskopf, D. (Apr 2007). "The G1246A polymorphism in the hypocretin receptor 2 gene is not associated with treatment response in cluster headache.". Cephalalgia 27 (4): 363-7. doi:10.1111/j.1468-2982.2007.01287.x. PMID 17376114. 
  • Baumber, L.; Sjöstrand, C.; Leone, M.; Harty, H.; Bussone, G.; Hillert, J.; Trembath, RC.; Russell, MB. (Jun 2006). "A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort.". Neurology 66 (12): 1888-93. doi:10.1212/01.wnl.0000219765.95038.d7. PMID 16801656. 
  • Schürks, M.; Kurth, T.; Geissler, I.; Tessmann, G.; Diener, HC.; Rosskopf, D. (Jun 2006). "Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene.". Neurology 66 (12): 1917-9. doi:10.1212/01.wnl.0000215852.35329.34. PMID 16554494. 
  • Holland, PR.; Akerman, S.; Goadsby, PJ. (Dec 2005). "Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.". J Pharmacol Exp Ther 315 (3): 1380-5. doi:10.1124/jpet.105.090951. PMID 16160082. 
  • Rainero, I.; Gallone, S.; Valfrè, W.; Ferrero, M.; Angilella, G.; Rivoiro, C.; Rubino, E.; De Martino, P.; et al. (Oct 2004). "A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache.". Neurology 63 (7): 1286-8. PMID 15477554. 
  • Bartsch, T.; Levy, MJ.; Knight, YE.; Goadsby, PJ. (Jun 2004). "Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.". Pain 109 (3): 367-78. doi:10.1016/j.pain.2004.02.005. PMID 15157698. 

Siehe auch:

Externe Links